(19)
(11) EP 2 288 622 A2

(12)

(88) Date of publication A3:
14.01.2010

(43) Date of publication:
02.03.2011 Bulletin 2011/09

(21) Application number: 09743241.3

(22) Date of filing: 16.04.2009
(51) International Patent Classification (IPC): 
C07K 14/745(2006.01)
(86) International application number:
PCT/US2009/040813
(87) International publication number:
WO 2009/137254 (12.11.2009 Gazette 2009/46)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 16.04.2008 US 124567 P
17.04.2008 US 45961 P

(71) Applicants:
  • Bayer HealthCare LLC
    Tarrytown, NY 10591 (US)
  • Bayer Schering Pharma Aktiengesellschaft
    13353 Berlin (DE)

(72) Inventors:
  • BROOKS, Alan
    Clayton, CA 94517 (US)
  • MURPHY, John, E.
    Berkeley, CA 94707 (US)
  • SETO, Marian
    Orinda, CA 94563 (US)
  • JIANG, Xiaoqiao
    Concord, CA 94518 (US)
  • PATEL, Chandra
    Foster City, CA 94404 (US)
  • GRITZAN, Uwe
    50823 Köln (DE)
  • KIRCHNER, Kornelia
    50226 Frechen (DE)
  • HAUPTS, Ulrich
    51519 Odenthal (DE)

(74) Representative: Burkert, Frank 
Bayer HealthCare AG LP-PL, Q18
51368 Leverkusen
51368 Leverkusen (DE)

   


(54) MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF